Ignite Technology Transfer Office

Ask An Expert
Success Stories

Two Researchers from NUI Galway, Dr Pat McDonnell and Dr. Noel Harrison are leading an Orthopedic Innovation initiative that is currently generating a lot of national and international interest.  With the support of Enterprise Ireland and in particular their Commercialisation Fund offering, the team are developing a pipeline of novel orthopedic devices and platforms technologies.  Each offering has been selected and designed on the basis of significant clinical, market and industry input. 

OsteoAnchor is a unique, patent-protected surface technology that addresses the significant issue of implant loosening, due to insufficient fixation during the operation, resulting in reduced implant lifespan.  OsteoAnchor consists of an optimal density of claw-like features protruding from a porous lattice on the surface of the implant.  These claws embed into the patient’s bone during the operation, providing excellent and immediate fixation, thus facilitating an improved long-term lifespan of the implant by long-term bone ingrowth.  Backed by extremely positive large animal model data, OsteoAnchor is superior to every other surface coating on the market today. 

OsteoHipfix is a functionally superior hip fracture fixation device that will challenge existing DHS-plate and IM nail devices currently dominating a significant and growing market.  Its unique, patent-protected design provides more stable fixation and results in a more natural biomechanical response in the hip when the patient begins load bearing, thus improving fracture healing and reducing the recovery time.  The device is also more minimally invasive than competing products (only a single 3 cm incision is required) and will enter clinical trials in 2015. 

The Team have deservedly received a lot of investor and media attention, featuring in the national press, on RTE's flagship program 'The Late Late Show' and at international technology exhibitions such as Enterprise Ireland Big Ideas and the annual meeting for the American Academy of Orthopaedic Surgeons (AAOS).  The team plans to commence market penetration of their product pipeline in 2015 via a spin-off company from NUI Galway.

FaLang translation system by Faboba